Following the MULTIR Hybrid Symposium on 2 October 2025 in Hannover and online, we invited Rob White of Melanoma Patient Network Europe (MPNE), who chaired the closing panel discussion, to share his reflections on some of the questions raised during the event. While the symposium brought together clinicians, researchers, AI experts, industry, ethicists and patient advocates to explore how AI can transform cancer care, this conversation focuses specifically on what stayed with

On 4 December, the MULTIR project participated in the EU Cancer Mission Conference in Copenhagen, held under the framework of the EU Mission on Cancer. The project was represented by Prof. Harald Mischak (MOS) , who presented MULTIR’s work and its contribution to tackling the clinical challenge of variable patient responses to immunotherapy. His presentation emphasized the critical role of understanding tumour-host immune interactions in influencing treatment outcomes. The

On 2–3 October 2025, the MULTIR consortium held its 2nd Annual Meeting in Hannover, Germany. The event was kindly hosted by project partner MOS and ran in a hybrid format, with participants joining both on site and online from across Europe. A warm welcome in Hannover The meeting opened with a welcome from Prof. Lise Boussemart (INSERM–NUH), who thanked MOS for their hospitality and smooth organisation. She introduced the agenda for the two days, which combined project-wide u